| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |